12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Company News  |  Deals

Par Pharmaceutical, TPG deal

Investment firm TPG completed its acquisition of generics company Par for $50...

Read the full 39 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >